|
WDR47 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25039999999233E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.397820E-02 |
| Normal-vs-Stage2 |
7.739800E-02 |
| Normal-vs-Stage3 |
8.94270000051378E-07 |
| Normal-vs-Stage4 |
8.11179999837819E-08 |
| Stage1-vs-Stage2 |
7.004400E-01 |
| Stage1-vs-Stage3 |
2.139200E-03 |
| Stage1-vs-Stage4 |
3.172200E-04 |
| Stage2-vs-Stage3 |
9.686100E-02 |
| Stage2-vs-Stage4 |
3.735600E-02 |
| Stage3-vs-Stage4 |
3.905600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.92120000000107E-05 |
| Normal-vs-AfricanAmerican |
1.440860E-04 |
| Normal-vs-Asian |
4.717800E-01 |
| Caucasian-vs-AfricanAmerican |
1.844440E-01 |
| Caucasian-vs-Asian |
2.938100E-02 |
| AfricanAmerican-vs-Asian |
1.248160E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.20230000000277E-06 |
| Normal-vs-Female |
1.401750E-02 |
| Male-vs-Female |
1.890060E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.968000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.418780E-03 |
| Normal-vs-Age(61-80Yrs) |
2.27379999999666E-05 |
| Normal-vs-Age(81-100Yrs) |
9.703200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.921400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.975400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.113600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.790600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.520600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.344000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.899200E-01 |
| Normal-vs-Grade 2 |
8.363700E-02 |
| Normal-vs-Grade 3 |
3.696700000555E-07 |
| Normal-vs-Grade 4 |
3.00930003138689E-09 |
| Grade 1-vs-Grade 2 |
1.414240E-01 |
| Grade 1-vs-Grade 3 |
2.222800E-03 |
| Grade 1-vs-Grade 4 |
1.433940E-04 |
| Grade 2-vs-Grade 3 |
1.816640E-04 |
| Grade 2-vs-Grade 4 |
1.03780000004772E-06 |
| Grade 3-vs-Grade 4 |
1.506300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.923800E-01 |
| Normal-vs-ccB subtype |
9.615899998483E-08 |
| ccA subtype-vs-ccB subtype |
1.58080000201011E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.781300E-04 |
| Normal-vs-N1 |
5.417900E-02 |
| N0-vs-N1 |
3.073200E-01 |
|
|
